SDZNY

Congress Trades

Name	Value	Action	Amount Range	Price	Current Price
George WhitesidesDemocrat $8.0k OtherMar 24, 2025 $1k-$15k -- --

News

zacks.com3 Generic Drug Stocks to Watch as New Growth Drivers Emergezacks.comJun 5

zacks.comSDZNY or UTHR: Which Is the Better Value Stock Right Now?zacks.comJun 4

reuters.comGeneric drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics importsreuters.comMay 28

zacks.comSandoz Group AG Sponsored ADR (SDZNY) Upgraded to Buy: Here's What You Should Knowzacks.comMay 19

zacks.comUSNA or SDZNY: Which Is the Better Value Stock Right Now?zacks.comMay 12

Trade SDZNY

About Sandoz Group AG

Sandoz Group AG operates as a global pharmaceutical enterprise, primarily focusing on the development, manufacturing, and commercialization of generic medicines and biosimilars. Their offerings include finished dosage forms of small molecule pharmaceuticals, often supplied to other businesses. Additionally, the company provides protein-based and other biotechnology-derived products, along with specialized biotechnology manufacturing services. Sandoz also produces anti-infective compounds, specifically active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

CEO: Richard Saynor
IPO Date: Oct 4, 2023

Market Data

Open: $85.24
High: $86.89
Low: $83.97
Volume: 5.5K
Avg Volume: 30.1K
52W High: $94.15
52W Low: $52.01

Valuation

Market Cap: $36B
Enterprise Value: $40B
Dividend Yield: 1.02%

Financials

Free Cash Flow: $810M
Revenue: $11B
Net Income: $919M
Cash: $1.7B
Debt: $5.7B

Events

DividendApr 14

$1.02074